Outlook

The Company anticipates full year 2012 net sales to be in the range of $472 million to $489 million, as compared to $512.9 million in 2011.

The Company anticipates full year 2012 as-adjusted earnings per share excluding stock-based compensation to be in the range of $0.26 to $0.36 per diluted share, as compared to $0.84 per diluted share in 2011. The Company’s earnings target excludes non-compete and transition costs associated with converting a major portion of independent foot and ankle territories to direct, costs associated with the previously announced cost restructuring, possible future acquisitions, other material future business developments, non-cash stock-based compensation expense, and costs associated with the Company’s DPA (including the associated independent monitor).

As noted above, the Company’s earnings target excludes the impact of non-cash stock-based compensation charges. While the amount of the non-cash stock-based compensation charges will vary depending upon a number of factors, the Company currently estimates that the after-tax impact of those expenses will be approximately $0.18 per diluted share for the full year 2012. Therefore, the Company anticipates full year 2012 as-adjusted earnings per share including stock-based compensation to be in the range of $0.08 to $0.18 per diluted share.

With regard to restructuring charges, the Company now anticipates incurring pre-tax restructuring charges related to the cost restructuring plan announced in September 2011 to range from $18 million to $25 million, of which $16.9 million of these charges have been incurred to date. The Company expects the remaining charges to be recorded during the first half of 2012.

From a cash flow perspective, the Company anticipates significant improvement over 2011 with 2012 free cash flow anticipated to be in the range of $25 million to $30 million, which represents annualized growth of 73% to 107%.

The Company’s anticipated ranges for net sales, adjusted earnings per share, non-cash stock-based compensation charges, restructuring charges and free cash flow are forward-looking statements. They are subject to various risks and uncertainties that could cause the Company’s actual results to differ materially from the anticipated targets. The anticipated targets are not predictions of the Company’s actual performance. See the cautionary information about forward-looking statements in the “Safe-Harbor Statement” section of this press release.

If you liked this article you might like

These Stocks Are Changing Course

Here’s Why Wright Medical (WMGI) Stock Is Jumping Today

Wright Medical Group (WMGI) Marked As A Barbarian At The Gate

Analysts' Actions -- Darden, MetLife, Pandora, Yelp and More

Barbarian At The Gate: Wright Medical Group (WMGI)